Cytek Biosciences, Inc.
CTKB
NASDAQ·Healthcare·Medical - Devices·Mkt cap $607.0M
$4.70
▲ 0.00%
P/E
-12.27
Mkt Cap
$607.0M
52-Wk Range
$3.28–$6.18
52-Week Range
$3.28 - $6.18
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 14.6% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
3 reasons
- Proprietary full-spectrum profiling technology enabling superior fluorescence detection and cell characterization
- Integrated software platform (SpectroFlo) providing seamless workflow optimization and data analysis
- Comprehensive product ecosystem combining instruments, reagents, and automation for complete cell analysis solutions
Bear Case
1 risk
- Average volatility.
Growth
Stable outlook
Increasing adoption of advanced flow cytometry in immunotherapy and personalized medicine development
Value
Deep value opportunity - significant discount to Medical Devices peers
Momentum
Strong
+16.3% over 3m
Quality
Strong
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying CTKB right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 4, 2026
AUG 5, 2026
Reported EPS of -$0.05 vs -$0.09 consensus (+46.4% surprise). Revenue of $48.1M vs $47.3M expected (+1.8%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+46.4%
Revenue trend · last 8Q
—
-1%
-8%
-2%
+2%
+8%
+6%
+6%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$51.5M
$57.5M
$41.5M
$45.6M
$52.3M
$62.1M
$44.1M
$48.1M
Margins · last 8Q
Gross
58.9%
Operating
-23.7%
Profit
-25.3%
Wall Street consensus
2 analysts · 50% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
50%
Hold
50%
Sell
0%
Median Price Target
—
Latest: Stephens · $4.75 · May 13, 2026
vs Industry
How CTKB stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related